自動廃棄機能付き注射器市場：適応症別、用途別、エンドユーザー別-2025-2030年の世界予測

自動廃棄機能付き注射器市場は、2023年に232億8,000万米ドルと評価され、2024年には259億4,000万米ドルに達すると予測され、CAGR 11.54％で成長し、2030年には500億1,000万米ドルに達すると予測されています。

自動廃棄機能付き注射器は、再使用を防止するように設計された特殊な医療機器であり、不潔な注射針によって感染症が広がるリスクを大幅に低減します。1回の使用で自動的にロックまたは無効化され、世界の医療安全基準に適合しています。これらの注射器の必要性は、特にHIVや肝炎のような感染症が蔓延している発展途上地域における、安全な注射の実践の必要性によってもたらされています。これらの注射器は、予防接種プログラム、薬剤投与、病院や診療所での医療介入に広く応用されています。最終用途の範囲は、ヘルスケア施設、公衆衛生機関、予防接種キャンペーンなど世界的に広がっています。政府のイニシアチブの高まりとヘルスケア支出の増加は、この市場の重要な成長要因です。さらに、現在進行中のCOVID-19パンデミックは、安全で効率的なワクチン接種方法に対する需要を高めており、自動脱着式注射器メーカーが市場を拡大する極めて重要な機会となっています。技術の進歩によって強化されたこれらの注射器は、ワクチン接種管理のためのデジタル追跡システムの統合や、自動化による生産効率の向上など、技術革新の可能性を提供しています。しかし、市場の成長には、特に低資源環境における製造コストの高さや、これらの機器に関するヘルスケアの普及と従事者のトレーニングの必要性といった課題があります。医療インフラの地域格差は、市場浸透をさらに複雑にしています。業界の性質上、激しい競争と規制があり、数多くの企業が製品の差別化と厳しい保健ガイドラインの遵守に注力しています。企業は、環境への配慮から生分解性素材を模索し、費用対効果の高い製造技術を開発することで、技術革新を目指すことができます。政府機関やNGOとのパートナーシップを拡大し、特に十分なサービスを受けていない地域で広く流通させることも、戦略的チャンスとなります。競争力と成長を維持するため、企業は技術のアップグレードと、ヘルスケア・ニーズが高まる新興市場での事業拡大に注力すべきです。

市場力学：急速に進化する自動廃棄機能付き注射器市場の主要市場インサイトを公開

自動廃棄機能付き注射器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 針刺し損傷と交差感染の発生率の上昇
  • 自動廃棄機能付き注射器の使用に対するヘルスケア組織の大幅な嗜好性
  • 予防接種に対する需要の高まり
• 市場抑制要因
  • 調達コストと原材料費の高騰
• 市場機会
  • 大規模なキャンペーンへの応用範囲の拡大
  • 自動廃棄機能付き注射器における継続的な進歩
• 市場の課題
  • 安全でない注射方法に関する懸念と物流上の課題

ポーターのファイブフォース：自動廃棄機能付き注射器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：自動廃棄機能付き注射器市場における外部からの影響の把握

外部マクロ環境要因は、自動廃棄機能付き注射器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア：分析自動廃棄機能付き注射器市場における競合情勢の把握

自動廃棄機能付き注射器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス：自動廃棄機能付き注射器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、自動廃棄機能付き注射器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：自動廃棄機能付き注射器市場における成功への道筋を描く

自動廃棄機能付き注射器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 針刺し事故と交差感染の発生率上昇
    • ヘルスケア機関は自動廃棄機能付き注射器の使用を強く好んでいる
    • 予防接種の需要増加
  • 抑制要因
    • 調達コストと原材料費が高い
  • 機会
    • 大量申請キャンペーンの範囲拡大
    • 自動廃棄機能付き注射器の継続的な進歩
  • 課題
    • 安全でない注射方法と物流上の課題に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 自動廃棄機能付き注射器市場適応症別

• 感染症
• 炎症性疾患/自己免疫疾患

第7章 自動廃棄機能付き注射器市場：用途別

• 採血
• ドラッグデリバリー
• 予防接種

第8章 自動廃棄機能付き注射器市場：エンドユーザー別

• 外来手術センター
• 診断検査室
• 病院

第9章 南北アメリカの自動廃棄機能付き注射器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の自動廃棄機能付き注射器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの自動廃棄機能付き注射器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AccuPoint by AdvaCare Pharma
• Al Shifa Medical Products Co.
• Apple Syringe
• Becton Dickinson & Company
• Duopross Meditech Corp.
• Hindustan Syringes & Medical Devices Ltd
• Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
• Injecto A/S
• Iscon Surgicals Ltd.
• JMI SYRINGES & MEDICAL DEVICES LTD.
• Merck KGaA
• PT Oneject Indonesia
• Retractable Technologies, Inc.
• Sanavita Pharmaceuticals GmbH
• Shandong Zhushi Pharmaceutical Group Co.,Ltd.
• Shanghai Kohope Medical Devices Co., Ltd.
• Shenzhen Medis Medical
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. AUTO-DISABLE SYRINGES MARKET RESEARCH PROCESS
• FIGURE 2. AUTO-DISABLE SYRINGES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AUTO-DISABLE SYRINGES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AUTO-DISABLE SYRINGES MARKET DYNAMICS
• TABLE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

The Auto-disable Syringes Market was valued at USD 23.28 billion in 2023, expected to reach USD 25.94 billion in 2024, and is projected to grow at a CAGR of 11.54%, to USD 50.01 billion by 2030.

Auto-disable syringes are specialized medical devices designed to prevent re-use, thus significantly reducing the risk of spreading infectious diseases through unclean needles. They automatically lock or disable after a single use, aligning with global health safety standards. The necessity for these syringes is driven by the need for safe injection practices, especially in developing regions where infectious diseases like HIV and hepatitis are prevalent. These syringes are widely applied in immunization programs, drug administration, and medical interventions in hospitals and clinics. The end-use scope spans across healthcare facilities, public health organizations, and vaccination campaigns globally. Growing government initiatives and increasing healthcare expenditure are significant growth factors in this market. Additionally, the ongoing COVID-19 pandemic has heightened the demand for secure and efficient vaccination methods, presenting a pivotal opportunity for auto-disable syringe manufacturers to expand their market footprint. Reinforced by technology advancements, these syringes offer potential for innovation such as integrating digital tracking systems for vaccination management and increased production efficiency through automation. However, market growth faces challenges like high production costs, especially in low-resource settings, and the need for spreading awareness and training healthcare workers about these devices. Regional disparities in health infrastructure further complicate market penetration. The industry's nature is intensely competitive and regulated, with numerous players focusing on product differentiation and adherence to stringent health guidelines. Companies can target innovation by exploring biodegradable materials to align with environmental concerns and developing cost-effective manufacturing techniques. Expanding partnerships with government bodies and NGOs for widespread distribution, especially in under-served areas, also represents a strategic opportunity. To maintain competitiveness and growth, businesses should focus on technological upgrades and expanding their reach in emerging markets with increasing healthcare needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auto-disable Syringes Market

The Auto-disable Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of needle stick injuries and cross infection
  • Significant preference of healthcare organizations towards the use of auto-disable syringes
  • Increasing demand for immunization coverage
• Market Restraints
  • High cost of procurement and raw material
• Market Opportunities
  • Increasing scope in mass application campaign
  • Ongoing advancements in auto-disable syringes
• Market Challenges
  • Concern regarding unsafe injection practices and logistic challenges

Porter's Five Forces: A Strategic Tool for Navigating the Auto-disable Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auto-disable Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auto-disable Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auto-disable Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auto-disable Syringes Market

A detailed market share analysis in the Auto-disable Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auto-disable Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auto-disable Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auto-disable Syringes Market

A strategic analysis of the Auto-disable Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Infectious Diseases and Inflammatory/Auto-Immune Diseases.
• Based on Application, market is studied across Blood Collection, Drug Delivery, and Vaccination.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of needle stick injuries and cross infection
    • 5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
    • 5.1.1.3. Increasing demand for immunization coverage
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of procurement and raw material
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing scope in mass application campaign
    • 5.1.3.2. Ongoing advancements in auto-disable syringes
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Auto-disable Syringes Market, by Indication

• 6.1. Introduction
• 6.2. Infectious Diseases
• 6.3. Inflammatory/Auto-Immune Diseases

7. Auto-disable Syringes Market, by Application

• 7.1. Introduction
• 7.2. Blood Collection
• 7.3. Drug Delivery
• 7.4. Vaccination

8. Auto-disable Syringes Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals

9. Americas Auto-disable Syringes Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Auto-disable Syringes Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Auto-disable Syringes Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AccuPoint by AdvaCare Pharma
• 2. Al Shifa Medical Products Co.
• 3. Apple Syringe
• 4. Becton Dickinson & Company
• 5. Duopross Meditech Corp.
• 6. Hindustan Syringes & Medical Devices Ltd
• 7. Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
• 8. Injecto A/S
• 9. Iscon Surgicals Ltd.
• 10. JMI SYRINGES & MEDICAL DEVICES LTD.
• 11. Merck KGaA
• 12. PT Oneject Indonesia
• 13. Retractable Technologies, Inc.
• 14. Sanavita Pharmaceuticals GmbH
• 15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
• 16. Shanghai Kohope Medical Devices Co., Ltd.
• 17. Shenzhen Medis Medical
• 18. Terumo Corporation